Gate Bio is a startup based in the United States, 1 tracked investor.
Based in the United States, Gate Bio is a startup. Brouky records 1 investor associated with the company.
Gate Bio develops small molecule drugs called Molecular Gates that selectively block and eliminate harmful extracellular proteins by preventing their secretion, aiming to treat diseases caused by those proteins.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.